Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chlorpromazines and cancer.

Literature DB >> 4115079

Chlorpromazines and cancer.

L K Csatary.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Chlorpromazine

Year: 1972 PMID： 4115079 DOI： 10.1016/s0140-6736(72)92955-8

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Cancer and the Dopamine D₂ Receptor: A Pharmacological Perspective.

Authors: Jillian S Weissenrieder; Jeffrey D Neighbors; Richard B Mailman; Raymond J Hohl
Journal: J Pharmacol Exp Ther Date: 2019-04-18 Impact factor: 4.030

Review 2. Understanding the role of dopamine in cancer: past, present and future.

Authors: Christopher E Grant; Amy L Flis; Bríd M Ryan
Journal: Carcinogenesis Date: 2022-06-27 Impact factor: 4.741

Review 3. A bibliometric review of drug repurposing.

Authors: Nancy C Baker; Sean Ekins; Antony J Williams; Alexander Tropsha
Journal: Drug Discov Today Date: 2018-01-09 Impact factor: 7.851

4. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Authors: Sokbom Kang; Seung Myung Dong; Boh-Ram Kim; Mi Sun Park; Barry Trink; Hyun-Jung Byun; Seung Bae Rho
Journal: Apoptosis Date: 2012-09 Impact factor: 4.677

Review 5. Cancer and schizophrenia: is there a paradox?

Authors: Richard Hodgson; Hiram J Wildgust; Chris J Bushe
Journal: J Psychopharmacol Date: 2010-11 Impact factor: 4.153

6. Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis.

Authors: Antonio Preti; Daniel R Wilson
Journal: Psychiatry Investig Date: 2010-12-15 Impact factor: 2.505

7. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro.

Authors: Silvia Matteoni; Paola Matarrese; Barbara Ascione; Mariachiara Buccarelli; Lucia Ricci-Vitiani; Roberto Pallini; Veronica Villani; Andrea Pace; Marco G Paggi; Claudia Abbruzzese
Journal: Front Oncol Date: 2021-02-26 Impact factor: 6.244

Chlorpromazines and cancer.

Review 1. Cancer and the Dopamine D₂ Receptor: A Pharmacological Perspective.

Review 2. Understanding the role of dopamine in cancer: past, present and future.

Review 3. A bibliometric review of drug repurposing.

4. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Review 5. Cancer and schizophrenia: is there a paradox?

6. Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis.

7. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro.

8. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Review 9. Drug rechanneling: A novel paradigm for cancer treatment.

10. Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer.

Chlorpromazines and cancer.

Review 1. Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective.

Review 2. Understanding the role of dopamine in cancer: past, present and future.

Review 3. A bibliometric review of drug repurposing.

4. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Review 5. Cancer and schizophrenia: is there a paradox?

6. Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis.

7. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro.

8. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Review 9. Drug rechanneling: A novel paradigm for cancer treatment.

10. Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer.

Review 1. Cancer and the Dopamine D₂ Receptor: A Pharmacological Perspective.